Table 1. Consolidating translational science. The proposed National Center for Advancing Translational Sciences (NCATS) would bring together existing NIH translational programs, which had a combined budget of over $590 million in the fiscal year that ended Sept. 30. It would also include Cures Acceleration Network, which was authorized in the Patient Protection and Affordable Care Act but has not yet received appropriations.
Source: NIH


FY10 budget ($M)

The Clinical and Translational Science Awards (CTSAs), which support a national consortium of medical research institutions.


The Molecular Libraries and Imaging program, which includes a consortium that performs high throughput screening against a collection of 300,000 small molecules.


The Therapeutics for Rare and Neglected Diseases (TRND) program, which performs preclinical and early clinical development of new drugs.


The Rapid Access to Interventional Development (RAID) program, which assists translational research, including synthesis and scale up production of small molecules, peptides, oligonucleotides, gene vectors, recombinant proteins and mAbs.


The NIH-FDA Regulatory Science Initiative, which is a collaborative effort to conduct and fund regulatory science research.


The Cures Acceleration Network, which will fund collaborations between government agencies and companies to speed product development.

Not applicable